Atsushi Hijikata

Associate Professor

Tokyo University of Pharmacy and Life Sciences

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Atsushi Hijikata is an Associate Professor at Tokyo University of Pharmacy and Life Sciences in Japan. His research areas focus on the genetics of autism spectrum disorders, molecular mechanisms of psoriasis, and the cellular responses to environmental changes. Dr. Hijikata has published recent articles exploring a range of topics, including neurodegeneration, COVID-19-related mortality, and potential therapeutic compounds against SARS-CoV-2.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Yoshinori Hasegawa

Kazusa DNA Research Institute

JAPAN

View details

Tsuyoshi Miyakawa

Fujita Health University

JAPAN

View details

Yohei Miyanoiri

Designated assistant professor

Nagoya University

JAPAN

View details

Masafumi Shionyu

Nagahama Institute of Bio-Science and Technology

JAPAN

View details

Naoko Okiyama

Professor

Tokyo Medical and Dental University

JAPAN

View details

Mikita Suyama

Kyushu University

JAPAN

View details

Toshiki Takenouchi

JAPAN

View details

Kazushi Izawa

JAPAN

View details

Masaaki Nishiyama

Professor

Kanazawa University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Atsushi Hijikata

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

The complex etiology of autism spectrum disorder due to missense mutations of CHD8

Exome-wide benchmark of difficult-to-sequence regions using short-read next-generation DNA sequencing

Generalisierte pustulöse Psoriasis, die sich bei einem Patienten mit einer NFKB2‐Variante entwickelte

Generalized pustular psoriasis that developed in a patient with an NFKB2 variant

Changes in the hydrophobic network of the FliGMC domain induce rotational switching of the flagellar motor

A novel variant of NR5A1, p.R350W implicates potential interactions with unknown co-factors or ligands

Case Report: Molecular autopsy underlie COVID-19-associated sudden, unexplained child mortality

Cellular response of Parachlorella kessleri to a solid surface culture environment

Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy

Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2

Role of Scl39a13/ZIP13 in cardiovascular homeostasis

Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation

Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins

Knowledge‐based structural models of SARS‐CoV‐2 proteins and their complexes with potential drugs

Collaborators (9)

Yoshinori Hasegawa

Tsuyoshi Miyakawa

Yohei Miyanoiri

Masafumi Shionyu

Naoko Okiyama

Mikita Suyama

Toshiki Takenouchi

Kazushi Izawa

Masaaki Nishiyama

Make your next move.